LOS ANGELES (KABC) -- Leading HIV researchers announced important new developments in HIV research at the 23rd International AIDS Conference (AIDS2020: Virtual) today.
This includes what may be the first report of an adult with HIV to achieve long-term HIV remission without the need for a bone marrow transplant and new data showing that long-acting injectable cabotegravir is superior to daily oral Truvada for pre-exposure prophylaxis (PrEP).
"Since 1985 the International AIDS Conference has helped answer the most pressing research questions in HIV, and this year is no different," Anton Pozniak, President of the International AIDS Society and International Chair of AIDS 2020: Virtual, said. "The studies presented at AIDS 2020: Virtual advance our knowledge on multiple fronts, knowledge that can potentially help the communities and regions most impacted by HIV worldwide."
Data presented today by Ricardo Diaz of the University of Sao Paulo revealed that one of the five individuals receiving this treatment regimen, a 34-year-old Brazilian male diagnosed with HIV in 2012, has maintained long-term HIV remission without the need for a bone marrow transplant. Notably, 57 weeks after structured treatment interruption, his HIV DNA in cells and his HIV antibody test remains negative.
The presenter noted that the findings are exciting but preliminary and that further analyses into viral cultivation and sequential HIV antibody profile and detection are ongoing.
AIDS2020: Virtual Daily presents the best in breaking HIV science from the 23rd International AIDS Conference (AIDS 2020: Virtual). The 15-minute daily show also features high profile guests, as well as community members from all over the world engaging in conversation. AIDS2020: Virtual Daily is hosted by ABC7's Karl Schmid in partnership with AIDS2020 Virtual and the show "Plus Life".
"Plus Life" premieres on Localish TV on Sunday, July 12 at 9 a.m. You can find Localish TV over the air on 7.2 and on select cable channels (COX 796/1133, Frontier 467, Google Fibre 70, Mediacom 520 and Spectrum 1246). The weekly show is focused on encouraging viewers to live their best lives and will feature topical interviews and celebrity guests.
'Pose' star and Emmy winner Billy Porter talks HIV prevention, treatment and stigma at AIDS2020: Virtual
Billy Porter on HIV, breaking news and exciting developments at AIDS2020: Virtual
More TOP STORIES News